Is the Xero (ASX:XRO) share price heading to $165?

Could the Xero share price be heading to $165?

| More on:
a group of people sit around a computer in an office environment.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Xero Limited (ASX: XRO) share price has been out of form in 2021.

Since the start of the year, the cloud accounting and business platform provider's shares have gained only 1%.

This compares unfavourably to the S&P/ASX 200 Index (ASX: XJO) and its 11% gain this year.

Is the Xero share price good value?

The good news is that one leading broker expects the Xero share price performance to improve.

According to a recent note out of Goldman Sachs, the broker has a buy rating and $165.00 price target on the company's shares.

Based on the current Xero share price, this implies potential upside of 10% over the next 12 months.

What did the broker say?

Goldman Sachs is positive on the Xero share price due to its belief that the company is well-placed for strong revenue growth over the coming years.

In fact, the broker expects its revenue to double over the next few years thanks to subscriber growth and the monetisation of its user base.

Goldman commented: "We expect XRO revenue to double across FY21-24E (+26% CAGR), driven by: (1) ARPU growth from the recently announced price rises (benefiting FY22/23E) and the introduction of this app store fee (benefiting FY23/24E); (2) Subscriber growth, given accelerating subscriber growth across all geographies in 2H21, and strong recent traction from its Enterprise strategy (i.e. recently signed a Global partnership with DFK, the 7th largest Global Accounting Association, to complement agreements with BDO/RSM); and (3) M&A, with the Planday acquisition to contribute +3% growth in FY22E."

But Goldman doesn't necessarily expect its revenue growth to stop there. The broker is forecasting revenue of NZ$3,699 million and EBITDA of NZ$1,263 million in FY 2030. This compares to its revenue estimate of NZ$1,129 million and EBITDA estimate of NZ$209 million for FY 2022.

Overall, if the company delivers on its estimates, the broker appears to believe the Xero share price will generate strong returns for investors. This could make it a top long term option for investors.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Xero. The Motley Fool Australia owns shares of and has recommended Xero. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Broker Notes

Leading broker tips 50%+ upside for IDP Education shares

The team at Macquarie thinks this beaten down stock could be a buy.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
Broker Notes

Bell Potter names the best ASX 200 stocks to buy in June

The broker is feeling bullish on these names this month. Let's find out why.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Broker Notes

Bell Potter says this ASX 200 share can rise 25%

Let's see what the broker is saying about this stock.

Read more »

Stethoscope with a piggy bank in the middle.
Broker Notes

Australian health insurance: Does Macquarie prefer Medibank or NIB shares?

Medibank and NIB shares have both surged in 2025. Here’s what Macquarie expects now.

Read more »

Man smiling at a laptop because of a rising share price.
Broker Notes

9 ASX 200 shares just upgraded to strong buy ratings

Brokers have upgraded these shares amid expectations of price growth over the next 12 months.

Read more »

Red sell button on an Apple keyboard.
Broker Notes

Sell alert! Brokers say pull the plug on these 3 ASX 200 shares

Experts say it's time to press the sell button on these ASX 200 shares. Find out why.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Broker Notes

Macquarie forecasts 40% upside for this ASX All Ords stock

Let's see which stock the broker is tipping as a buy.

Read more »